Repligen Corp. RGEN

NAS: RGEN | ISIN: US7599161095 13/05/2025

131,55 USD (-1,62%)

(-1,62%) 13/05/2025

Grafiek Repligen Corp.

Grafiek Repligen Corp.

1 dag1d -1,62%
1 week1w 3,68%
1 maand1m 3,37%
3 maanden3m -10,46%
6 maanden6m -7,64%
1 jaar1j -23,73%
5 jaar5j -0,32%

Repligen Corp. in het nieuws

Toon enkel gratis nieuws

9 september 2021 · Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies · Persbericht

17 maart 2021 · Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum · Persbericht

3 maart 2021 · Repligen Corporation to Present at Barclays Global Healthcare Conference · Persbericht

24 februari 2021 · Repligen Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

22 februari 2021 · Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference · Persbericht

11 februari 2021 · Repligen to Report Fourth Quarter and Full Year 2020 Financial Results · Persbericht

8 februari 2021 · Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines · Persbericht

4 januari 2021 · Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Repligen Corp.

Gezondheidstechnologie

Productie van biologische producten

Website: www.repligen.com

Hoofdzetel: Waltham, Massachusetts Verenigde Staten

CEO: Anthony Hunt

Werknemers: 1.007

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe